Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Genzyme Profits Vanish For Q2

July 22, 2010 6:49 am | News | Comments

Biotechnology company Genzyme Corp. said its profit shrank drastically in the second quarter because of falling sales and charges partly connected to its manufacturing problems.


Roche Half-Year Profits Leap 37%

July 22, 2010 6:45 am | by Bradley S. Klapper | News | Comments

Pharmaceuticals maker Roche Holding AG posted a 37 percent rise in six-month net profit on strong drug sales and lower costs related to its takeover of U.S.-based Genentech.


Eli Lilly Income Jumps 16%

July 22, 2010 6:37 am | by Tom Murphy | News | Comments

Eli Lilly and Co. said its second-quarter net income soared 16%, boosted in part by revenue growth from key drugs that face patent expirations in the coming years.


Enrollment Quashed For Avandia Safety Study

July 22, 2010 6:31 am | by Linda A. Johnson | News | Comments

Federal health officials are barring new patients from enrolling in a safety study of GlaxoSmithKline's controversial diabetes pill Avandia, a week after a panel of experts ruled that the drug increases heart risks.


FDA Reports Show Multiple Lapses At J & J Plant

July 22, 2010 6:21 am | by Linda A. Johnson | News | Comments

A dozen recent federal inspections of a Johnson & Johnson factory for heartburn and other nonprescription medicines show a host of violations that could affect the quality and makeup of the drugs.


Drug's Daily Newsletter Moves to ExactTarget

July 22, 2010 6:04 am | by Rita C. Peters, Editorial Director | News | Comments

In an effort to better serve its readers, Drug Discovery & Development has enhanced its e-newsletter distribution system. To ensure that you continue to receive prompt delivery of DDD Update, please update your spam filters and add to your safe sender list.

ELN Connector

July 21, 2010 8:53 am | Product Releases | Comments

Labtronics Inc., a world leader in laboratory automation has released a Connector for Nexxis ELN that allows the Electronic Laboratory Notebook to connect to any LIMS.


Gene Expression Assay

July 21, 2010 8:41 am | Drug Discovery & Development | Product Releases | Comments

Affymetrix, Inc. announced the launch of QuantiGene ViewRNA Assay formats, which enable a new era of “in situ multiplex gene expression analysis” by allowing drug screening of native cells and advancing the pace of biomarker disease research and stem cell studies.


Ricera Launches Foresight Service

July 21, 2010 8:35 am | News | Comments

Ricerca Biosciences, LLC, a uniquely integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, has announced its innovative similarity analysis service, Foresight.


Lilly Buys Alnara for $180M

July 21, 2010 8:30 am | News | Comments

Eli Lilly and Company announced that it has completed the acquisition of Alnara Pharmaceuticals, Inc., a privately-held company developing protein therapeutics for the treatment of metabolic diseases.


PROLOR Begins New Trial of Long-Lasting HGH

July 21, 2010 8:26 am | News | Comments

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, announced initiation of a Phase 2 clinical trial of hGH-CTP, the company’s proprietary biobetter version of human growth hormone (hGH).


Aganocide Effective Against Impetigo

July 21, 2010 8:00 am | News | Comments

NovaBay Pharmaceuticals, Inc. announced results from a Phase 2a trial that show its lead product candidate is safe and efficacious against the highly contagious skin infection impetigo, including those infections caused by drug-resistant MRSA.


Mechanical Stimulation Triggers Bone Growth

July 21, 2010 7:50 am | News | Comments

A long-standing question in bone biology has been answered: It is the spindly extensions of bone cells that sense mechanical stimulation and signal the release of bone-growth factors.


Antibiotic-Infection Tag Team Promising Against Malaria

July 21, 2010 7:47 am | News | Comments

If mice are administered an antibiotic for three days and are simultaneously infected with malaria, no parasites appear in the blood and life-threatening disease is averted. In addition, the animals treated in this manner also develop robust, long-term immunity against subsequent infections.


Stem Cells Mitigate Aftermath of Heart Attacks

July 21, 2010 7:31 am | News | Comments

Implanting tiny plastic scaffolds seeded with genetically engineered stem cells reduced organ damage and led to better cardiac function after a heart attack, according to a recent animal study.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.